[Detection of circulating malignant cells in patients with uveal melanoma].

Arq Bras Oftalmol 2007 Jul-Aug;70(4):593-8

Departamento de Oftalmologia e Patologia da McGill University Health Center & Henry C. Witelson Ocular Pathology Laboratory, Montreal, Canadá.

Purpose: The purpose of our study was to detect circulating malignant cells (CMCs) in oversea-shipped blood samples of patients with uveal melanoma diagnosed in Brazil. METHODOS: Melan-A and tyrosinase were the two markers used for the detection of CMCs, using reverse transcriptase nested polymerase chain reaction (RT-nested-PCR) in 6 patients with uveal melanoma. The expression of beta-actin and GAPDH were used to assess the quality of the material.

Results: Five patients (83.33%) tested positive for the presence of CMCs. The RT-nested-PCR was positive for melan-A in 4 patients (66.7%) and positive for tyrosinase in 4 (66.7%) of the 6 patients. Three (50%) patients were positive for both markers. One (16.7%) patient was negative for both markers. All negative controls were negative.

Conclusion: The quality of the blood samples shipped overseas, from patients with uveal melanoma, was preserved. The detection of CMCs using RT-nested-PCR was positive in the majority of the patients.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0004-27492007000400007DOI Listing
December 2007
3 Reads

Publication Analysis

Top Keywords

patients uveal
16
uveal melanoma
12
patients
9
rt-nested-pcr positive
8
cmcs rt-nested-pcr
8
blood samples
8
detection cmcs
8
circulating malignant
8
malignant cells
8
positive
5
beta-actin gapdh
4
expression beta-actin
4
negative controls
4
markers negative
4
gapdh assess
4
patients positive
4
negative markers
4
assess quality
4
melanoma expression
4
rt-nested-pcr patients
4

Similar Publications